Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tyrosol + Creatine (brand name: CreaSol® SSAT) is a nutraceutical combination supplement developed by MolTek Nutrition. It consists of tyrosol, a phenolic antioxidant (4-hydroxyphenylethanol) naturally derived from olive products, and creatine monohydrate, a well-established ergogenic aid. The combination is designed to enhance athletic performance, specifically improving upper-body strength endurance, training volume, and fatigue resistance in healthy adults. Mechanistically, it targets cellular energy production and mitochondrial function, with tyrosol providing additional antioxidant and anti-inflammatory benefits. A 2026 clinical study demonstrated synergistic effects between the two components that were not observed when administered individually.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tyrosol + creatine.